Ibrahim Qaddoumi

10.0k total citations
161 papers, 3.5k citations indexed

About

Ibrahim Qaddoumi is a scholar working on Genetics, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ibrahim Qaddoumi has authored 161 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Genetics, 51 papers in Neurology and 45 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ibrahim Qaddoumi's work include Glioma Diagnosis and Treatment (89 papers), Childhood Cancer Survivors' Quality of Life (41 papers) and Neuroblastoma Research and Treatments (41 papers). Ibrahim Qaddoumi is often cited by papers focused on Glioma Diagnosis and Treatment (89 papers), Childhood Cancer Survivors' Quality of Life (41 papers) and Neuroblastoma Research and Treatments (41 papers). Ibrahim Qaddoumi collaborates with scholars based in United States, Jordan and Canada. Ibrahim Qaddoumi's co-authors include Iyad Sultan, Amar Gajjar, Carlos Rodríguez‐Galindo, Andrea Ferrari, Matthew W. Wilson, Alberto Broniscer, Éric Bouffet, Ribhi Hazin, Maysa Al‐Hussaini and Thomas E. Merchant and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ibrahim Qaddoumi

151 papers receiving 3.5k citations

Peers

Ibrahim Qaddoumi
N.J. Tarbell United States
Uri Tabori Canada
J. Russell Geyer United States
Shannon M. MacDonald United States
Karen J. Marcus United States
Sharon L. Gardner United States
N.J. Tarbell United States
Ibrahim Qaddoumi
Citations per year, relative to Ibrahim Qaddoumi Ibrahim Qaddoumi (= 1×) peers N.J. Tarbell

Countries citing papers authored by Ibrahim Qaddoumi

Since Specialization
Citations

This map shows the geographic impact of Ibrahim Qaddoumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Qaddoumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Qaddoumi more than expected).

Fields of papers citing papers by Ibrahim Qaddoumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim Qaddoumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Qaddoumi. The network helps show where Ibrahim Qaddoumi may publish in the future.

Co-authorship network of co-authors of Ibrahim Qaddoumi

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim Qaddoumi. A scholar is included among the top collaborators of Ibrahim Qaddoumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim Qaddoumi. Ibrahim Qaddoumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berg, F.D. van den, Gemma Bryan, Dylan E. Graetz, et al.. (2025). Building pediatric neuro-oncology capacity in LMICs through multidisciplinary education and collaboration: a mixed-methods analysis. Neuro-Oncology Advances. 7(1). vdaf153–vdaf153.
2.
Fangusaro, Jason, Arzu Onar‐Thomas, Tina Young Poussaint, et al.. (2025). A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4. Neuro-Oncology. 27(9). 2415–2428. 2 indexed citations
4.
Robinson, Giles, Anna Vinitsky, Asim K. Bag, et al.. (2024). CTNI-70. RESULTS FROM THE PHASE 1 AND PHASE 1 EXPANSION COHORTS OF SJ901: A PHASE 1/2 TRIAL OF SINGLE-AGENT MIRDAMETINIB (PD-0325901) IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOW-GRADE GLIOMA. Neuro-Oncology. 26(Supplement_8). viii113–viii113. 1 indexed citations
5.
Klimo, Paul, Matthew D. Wood, Alan Davidson, et al.. (2024). Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma. UNC Libraries. 1 indexed citations
6.
Moreira, Daniel C., Ibrahim Qaddoumi, Thomas W. Bouldin, et al.. (2024). Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma. Neuro-Oncology. 26(7). 1327–1334. 9 indexed citations
7.
Moreira, Daniel C., Ibrahim Qaddoumi, Yichen Chen, et al.. (2023). Outcomes of SARS‐CoV‐2 infection in 126 children and adolescents with central nervous system tumors. Pediatric Blood & Cancer. 70(8). e30402–e30402. 1 indexed citations
8.
Moreira, Daniel C., Catherine G. Lam, Nickhill Bhakta, et al.. (2023). Tackling Pediatric Low-Grade Gliomas: A Global Perspective. JCO Global Oncology. 9(9). e2300017–e2300017. 7 indexed citations
9.
Baticulon, Ronnie E., et al.. (2023). The role of neurosurgery in advancing pediatric CNS tumor care worldwide. SHILAP Revista de lepidopterología. 3. 101748–101748. 6 indexed citations
10.
Qaddoumi, Ibrahim, et al.. (2023). Pediatric Neurosurgical Capacity for the Care of Children With CNS Tumors Worldwide: A Cross-Sectional Assessment. JCO Global Oncology. 9(9). e2200402–e2200402. 9 indexed citations
11.
Ward, Richard, Hannah M. Jones, Frederick A. Boop, et al.. (2022). Outcomes of Children With Low-Grade Gliomas in Low- and Middle-Income Countries: A Systematic Review. JCO Global Oncology. 8(8). e2200199–e2200199. 12 indexed citations
12.
Sherman, S., Ryuma Tanaka, & Ibrahim Qaddoumi. (2022). Psychiatric symptoms in children with low-grade glioma and craniopharyngioma: A systematic review. Journal of Psychiatric Research. 148. 240–249. 10 indexed citations
13.
Bag, Asim K., Noah D. Sabin, Scott N. Hwang, et al.. (2021). [11C]-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence. Journal of Nuclear Medicine. 63(5). jnumed.120.261891–jnumed.120.261891. 18 indexed citations
14.
Yousef, Yacoub A., Mustafa Mehyar, Iyad Sultan, et al.. (2020). How Telemedicine and Centralized Care Changed the Natural History of Retinoblastoma in a Developing Country. Ophthalmology. 128(1). 130–137. 35 indexed citations
15.
Moreira, Daniel C., Amar Gajjar, Zoltán Patay, et al.. (2020). Creation of a successful multidisciplinary course in pediatric neuro‐oncology with a systematic approach to curriculum development. Cancer. 127(7). 1126–1133. 8 indexed citations
16.
Benmiloud, Sarra, et al.. (2018). Time to diagnosis of pediatric brain tumors: a report from the Pediatric Hematology and Oncology Center in Rabat, Morocco. Child s Nervous System. 34(12). 2431–2440. 20 indexed citations
17.
Upadhyaya, Santhosh A., Shengjie Wu, Alberto Broniscer, et al.. (2017). Mortality in children with low‐grade glioma or glioneuronal tumors: A single‐institution study. Pediatric Blood & Cancer. 65(1). 17 indexed citations
18.
Rajagopal, Revathi, Dharmendra Ganesan, Kum Thong Wong, et al.. (2016). Challenges of Treating Childhood Medulloblastoma in a Country With Limited Resources: 20 Years of Experience at a Single Tertiary Center in Malaysia. Journal of Global Oncology. 3(2). 143–156. 19 indexed citations
19.
Parkes, Jeannette, Marc Hendricks, Peter Ssenyonga, et al.. (2014). SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings. Pediatric Blood & Cancer. 62(4). 553–564. 47 indexed citations
20.
Yousef, Yacoub A., et al.. (2011). Retinoblastoma in Jordan. Hematology/Oncology and Stem Cell Therapy. 4(3). 126–131. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026